Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort

NCT02890134 is registered in ClinicalTrials.gov with Fundación Pública Andaluza Progreso y Salud as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02890134 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
Lead sponsor
Fundación Pública Andaluza Progreso y Salud
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
July 31, 2018
Enrollment
215 (actual)
Sites
10

Conditions

As the registry lists them; a condition with its own page is linked.

systemic autoimmune diseases